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Abstract
Developing in vitro engineered hepatic tissues that exhibit stable phenotype is a major challenge in the field of hepatic
tissue engineering. However, the rapid dedifferentiation of hepatic parenchymal (hepatocytes) and non-parenchymal (liver
sinusoidal endothelial, LSEC) cell types when removed from their natural environment in vivo remains a major obstacle. The
primary goal of this study was to demonstrate that hepatic cells cultured in layered architectures could preserve or
potentially enhance liver-specific behavior of both cell types. Primary rat hepatocytes and rat LSECs (rLSECs) were cultured
in a layered three-dimensional (3D) configuration. The cell layers were separated by a chitosan-hyaluronic acid
polyelectrolyte multilayer (PEM), which served to mimic the Space of Disse. Hepatocytes and rLSECs exhibited several key
phenotypic characteristics over a twelve day culture period. Immunostaining for the sinusoidal endothelial 1 antibody (SE-1)
demonstrated that rLSECs cultured in the 3D hepatic model maintained this unique feature over twelve days. In contrast,
rLSECs cultured in monolayers lost their phenotype within three days. The unique stratified structure of the 3D culture
resulted in enhanced heterotypic cell-cell interactions, which led to improvements in hepatocyte functions. Albumin
production increased three to six fold in the rLSEC-PEM-Hepatocyte cultures. Only rLSEC-PEM-Hepatocyte cultures exhibited
increasing CYP1A1/2 and CYP3A activity. Well-defined bile canaliculi were observed only in the rLSEC-PEM-Hepatocyte
cultures. Together, these data suggest that rLSEC-PEM-Hepatocyte cultures are highly suitable models to monitor the
transformation of toxins in the liver and their transport out of this organ. In summary, these results indicate that the layered
rLSEC-PEM-hepatocyte model, which recapitulates key features of hepatic sinusoids, is a potentially powerful medium for
obtaining comprehensive knowledge on liver metabolism, detoxification and signaling pathways in vitro.
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Introduction
The liver is one of the largest organs in our bodies. It performs a
multitude of functions such as metabolism, detoxification, and
mediation of the body’s complex defense mechanisms. Two of the
most commonly observed cell types in the liver are hepatocytes
and liver sinusoidal endothelial cells (LSECs). Together, they
account for more than 80% of the liver’s mass. Hepatocytes are
responsible for several metabolic and detoxification functions that
are unique to the liver [1]. LSECs exhibit characteristics that are
distinct from endothelial cells that line other blood vessels. They
participate in metabolic activities, exhibit fenestrae [1,2] and are
often the initial target of hepatic toxicants [3]. LSECs also function
as a scavenger system in the liver by removing waste macromol-
ecules and play a vital role in the balance of lipids, cholesterol and
vitamins [4–10].
These primary hepatic cell types are well known to exhibit a
dramatic loss in their phenotypic characteristics when removed
from the organ [1]. Specifically, hepatocytes and LSECs
dedifferentiate within 72h when cultured as monolayers in vitro
[11–14]. Various approaches have been utilized to design in vitro
hepatocyte cultures in order to maintain their phenotype. For
instance, hepatocytes cultured in a collagen sandwich or in 2D co-
cultures with non-parenchymal cells remain stable over two an
extended period of time [12–14,15–21]. More recently, hepato-
cytes sandwiched between Matrigel layers were reported to exhibit
stable function [22]. Despite their advantages, collagen or Matrigel
sandwich cultures do not provide the complex multi-cellular
environment found in vivo, whereas 2D co-cultures do not mimic
the layered liver architecture. Maintaining the phenotype of
LSECs has proven to be equally difficult. Recently, studies have
demonstrated that modulating the microenvironment in LSEC
cultures can delay the dedifferentiation of LSECs [23–25]. For
example, LSECs cultured on extra-cellular matrices derived from
the liver, bladder or intestine maintained liver-specific character-
istics up to 3 days when cultured individually or up to 7 days when
co-cultured with primary hepatocytes [24]. Varying the cellular
microenvironment in combination with culturing LSECs with
fibroblasts and hepatocytes delayed the dedifferentiation of LSECs
up to 14 days [25]. The addition of growth factors such as vascular
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(HGF), and platelet derived growth factor (PDGF) can also
prolong the loss of LSEC-specific characteristics [26–28]. In spite
of these advances, it has proven extremely difficult to simultaneously
maintain the phenotypes of hepatocytes and LSECs in vitro.
Consequently, the multitude of critical hepatic functions that
hepatocytes and LSECs perform cannot be studied adequately or
monitored for long periods in vitro.
In vivo, hepatocytes and LSECs are separated by a protein-
based interface called the Space of Disse [1]. This is an interface
comprised of various extracellular matrix proteins and proteo-
glycans. The ECM is highly organized and composed of proteins
( c o l l a g e nt y p eI ,I I ,I V ,a n dV ) ,g lycoproteins (fibronectin,
laminin, tenascin, and osteonectin), proteoglycans (heparin
sulfate, and chondroitin sulfate), and glycosaminoglycans (hya-
luronan). The Space of Disse enables the diffusion of molecules
from the fenestrated LSEC layers to the hepatocytes and
t h e r e b ya c t sa sa‘ ‘ m o l e c u l a rs i e ve’’ [1]. We hypothesized that
constructing an in vitro model that mimicked the Space of Disse
might assist in delaying the de-differentiation of hepatic cells. In
previous attempts to test this hypothesis, we have reported the
assembly of 3D hepatic cellular constructs assembled from
primary hepatocytes, human umbilical vein endothelial cells
(HUVECs)/human LSECs (hLSECs) and a polyelectrolyte-
derived interfacial region that mimics the Space of Disse
[29,30]. We have previously demonstrated that an interface
comprised of polyelectrolyte multilayers (PEMs) enables the
assembly of the interfacial region with precise control over the
height, hydrated thickness and the modulus [29,30]. Since
polyelectrolytes are either cationic or anionic, the presence of a
PEM recapitulates the charged environment of the Space of
Disse. The PEM was deposited above a layer of hepatocytes and
was comprised of cationic (chitosan) and anionic (hyaluronic
acid) polyelectrolytes. Since several previous reports have
demonstrated the compatibility of chitosan as a substrate to
culture hepatocytes, chitosan was selected as the cationic PE [31–
33]. Hyaluronic acid (HA) is found inthe Space of Disse as well as
in the basal membranes of connective tissues and is a biomaterial
used for the culture of endothelial cells [34,35]. The height of the
PEM was determined to be approximately 30nm and 55nm for
five and fifteen layers respectively. The PEM exhibited a high
degree of hydration (1.01 mPas) and shear modulus values of
approximately 100kPa, similar to those observed within the liver
in vivo [30]. When human LSECs (hLSECs) were cultured on the
PEM-coated hepatocyte layer, the resulting construct exhibited
significantly enhanced hepatic properties in comparison to
hepatocyte monolayers or collagen sandwich cultures. However,
we did not monitor the phenotypes of the LSECs in these earlier
studies.
In this study, our goal was to incorporate primary rat LSECs
(rLSECs) into the 3D hepatic model to determine if such an
arrangement of hepatic cells would prevent or delay the
dedifferentiation of both hepatocytes and rLSECs. In the 3D
model reported herein, hepatocytes and rLSECs were separated
b yan a n o s c a l eP E Mt h a tc o u l dp o t e ntially mediate intercellular
signaling and ultimately promote heterotypic interactions. The
phenotypic characteristics of primary rat hepatocytes and
rLSECs were monitored through a combination of hepatocellu-
lar-specific assays and immunostaining. Hepatocyte function was
monitored through urea and albumin production, cytochrome
P450 enzyme kinetics, and by immunostaining for bile canaliculi.
For rLSECs, immunostaining for the sinusoidal endothelial
marker (SE-1) provided a convenient method to verify their
differentiated state.
Materials and Methods
Materials
Dulbecco’s modified eagle medium (DMEM) containing 4.5 g/
L glucose, phosphate-buffered saline (PBS), Earle’s balanced salt
solution (EBSS), Hank’s buffered salt solution (HBSS), ethoxy
resorufin, benzyloxy resorufin, resorufin, penicillin, streptomycin,
and trypsin-ethylenediaminetetraacetic acid were obtained from
Invitrogen Life Technologies (Carlsbad, CA). Type IV collage-
nase, HEPES (4-[2-hydroxyethyl] piperazine-1-ethanesulfonic
acid), glucagon, hydrocortisone, dicumarol, sodium dodecyl sulfate
(SDS), hydrogen peroxide, pronase, and glutaraldehye were
obtained from Sigma-Aldrich (St. Louis, MO). Endothelial cell
growth medium and supplements were obtained from ScienCell
Research Laboratories (San Diego, CA). Unless noted otherwise,
all other chemicals were obtained and used as received from Fisher
Scientific (Pittsburgh, PA).
Methods
Hepatocyte isolation and culture. Primary rat hepatocytes
were harvested from female Lewis rats (Harlan, Indianapolis, IN)
that weighed between 170–200g. Animal care and surgical
procedures were conducted in accordance with procedures
approved by Virginia Polytechnic Institute and State University’s
Institutional Animal Care and Use Committee (IACUC Protocol
10-062-CHE). A two-step in situ collagenase perfusion method was
utilized to excise the liver [12,13,29,30]. Briefly, rats were
anesthetized with 3 L/min of a gas mixture of 3% (v/v)
isofluorane/97% oxygen (Veterinary Anesthesia Systems Co.,
Bend, OR). The liver was perfused with Krebs Ringer Buffer
(KRB; 7.13 g/L sodium chloride, 2.1 g/L sodium bicarbonate,
1 g/L glucose, 4.76 g/L HEPES and 0.42 g/L potassium
chloride) that contained 1mM EDTA (ethylene diamine tetra
acetic acid), followed by perfusion with a 0.1% w/v collagenase
(Sigma, Type IV). Cell suspensions were filtered through nylon
meshes with porosity ranging from 250 to 62 mm (Small Parts,
Inc., Miramar, FL). Hepatocytes were separated using a Percoll
(Sigma-Aldrich) density centrifugation technique. Hepatocyte
viability was determined by trypan blue exclusion. Hepatocytes
were cultured on collagen-coated (rat tail, Type 1 collagen) 6-well
sterile tissue culture plates (Becton Dickinson Labware, Franklin
Lakes, NJ) and were maintained in culture medium that consisted
of DMEM supplemented with 10% heat-inactivated fetal bovine
serum (Hyclone, UT), 200 U/mL penicillin, 200 mg/mL
streptomycin, 20 ng/mL epidermal growth factor (BD
Biosciences, San Jose, CA), 0.5 U/mL insulin (USP, Rockville,
MD), 14 ng/mL glucagon and 7.5 mg/mL hydrocortisone. A
collagen gelling solution was prepared by mixing 9 parts of Type I
collagen (BD Biosciences) solution and 1 part of 106 DMEM.
Sterile 6-well tissue culture plates were coated with 0.5 ml of the
gelling solution and incubated at 37uC for 1h to promote gel
formation. Hepatocytes were seeded at a density of 1 million cells/
well. Hepatocyte cultures were maintained at 37uC in a humidified
gas mixture of 90% air/10% CO2. The culture medium was
replaced every 24h and medium samples were stored at 220uC for
further analysis.
Isolation and culture of primary rat LSECs. Primary rat
LSECs (rLSECs) were isolated from the supernatant taken from
the centrifugation steps for hepatocyte isolation as well as from
hepatic tissue fragments treated with pronase (0.02% (w/v)). The
resulting cell fraction was added to 25%/50% Percoll/PBS
gradients. Cells located at the interface between 25 and 50%
Percoll/PBS were collected for further separation. rLSECs were
separated from other non-parenchymal hepatic cells through a
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plastic surface at 37uC for 30 min. The non-adherent LSECs were
maintained in medium supplemented with 5% (v/v) fetal bovine
serum, 1% (v/v) endothelial cell growth supplement, 100 U/mL
penicillin, and 100 mg/mL streptomycin at 37uC under a
humidified gas mixture of 95% air/5% CO2.
Assembly of 3D constructs of primary rat hepatic
cells. Rat hepatocytes were cultured on collagen-gel coated
substrates and allowed to spread up to 72 h to form a confluent
monolayer [30]. Upon obtaining a confluent cell layer, a
polyelectrolyte multilayer (PEM) was deposited. The PEM was
comprised of alternating layers of chitosan (200–300kDa, 0.01%
(w/v)) and hyaluronic acid (.1610
6 kDa, 0.01% (w/v)). PEMs
were assembled on hepatocytes by first depositing a cationic PE on
the cell layer followed by the anionic PE. The exposure time for
each PE solution was approximately 1–2 minutes. The desired
number of layers was obtained through the sequential and alternate
deposition of PEs. At the end of the deposition procedure, the
sampleswererinsedin16PBSandsubsequentlymaintainedincell-
culture medium at 37uC. Thereafter, a layer of primary rat LSECs
was seeded. Typically, 25,000 (denoted as 25K) or 50,000 (denoted
as 50K) LSECs were added to each sample and non-adherent cells
were removed after 2 h. In order to visually observe the 3D primary
hepatic cell constructs, LSECs were labeled with a fluorescent,
membrane permeable dye (PKH26 Red Fluorescent Cell Linker
Kit; Sigma-Aldrich) prior to seeding. The culture medium was
replaced every 24hr and medium samples were collected and stored
220uC until further analysis. Cells were observed and imaged
under an inverted NikonTE-2000 (Nikon) microscopecoupled with
a Hamamatsu CCD camera.
Immunostaining for sinusoidal endothelial -1 (SE-1) LSEC
marker. LSECs were fixed in a 2% glutaraldehyde/PBS v/v
solution for 30 min at room temperature and subsequently
incubated with a 0.1% Triton X-100 solution to permeabilize
their membrane. The LSEC samples were placed overnight in a
blocking solution (1% BSA/PBS w/v) solution at 4uC. The
samples were first exposed to a primary antibody (SE-1, Immuno-
Biological Laboratories, Minneapolis, MN) for 2h at 37uC and
followed by exposure to a FITC-conjugated secondary antibody
(Sigma-Aldrich) for 1 hr at room temperature. Images were
acquired on a Zeiss LSM confocal microscope.
Urea and albumin production by primary rat hepa-
tocytes. Urea concentration of medium samples was
determined via its specific colorimetric reaction with diacetyl
monoxime using a commercially available assay kit (BUN Assay
kit; Stanbio Laboratory, Boerne, TX) [29,30]. Albumin
concentration of medium samples was analyzed by an enzyme-
linked immunosorbent assay (ELISA), in triplicate, utilizing a
polyclonal antibody to rat albumin (Cappel Laboratories, Aurora,
OH). The absorbance was measured on a SpectraMax M2
microplate reader (Molecular Devices, Sunnyvale, CA). Standard
curves were generated using purified rat albumin or urea diluted in
culture medium. The data reported were normalized to the DNA
content of hepatocytes.
Separation of hepatocytes and LSECs in 3D con-
structs. The 3D constructs comprised of primary rat
hepatocytes and LSECs were exposed to SE-1 antibody
conjugated DynabeadsH (Invitrogen). SE-1 antibody conjugated
Dynabeads were obtained by incubating mouse IgG-tagged
DynabeadsH (CELLection
TM Pan Mouse IgG Kit; Invitrogen)
with the SE-l antibody at room temperature for 20 min [28].
Thereafter the cell suspensions were incubated with SE-1 antibody-
tagged DynabeadsH for 20 min at 4uC in an orbital shaker.
DynabeadH-bound cells (LSEC fractions) were collected by a
magnet (DynaMag
TM-15; Invitrogen) and the supernatant
(hepatocytes) were transferred to a new tube. After separation, the
hepatocyte and rLSEC fractions were seeded on a collagen-coated
or fibronectin-coated substrate respectively. The number of cells for
each fraction was counted using a non-destructive imaging method.
Approximately fifty images were taken per sample to determine
purity. Analysis of the images based upon the distinctive polygonal
andelongated morphologyforhepatocytesandrLSECsrespectively
revealed the purity of cell populations to be greater than 95%.
Measurement of DNA content. Hepatocytes were lysed in a
0.1% SDS solution and stored at 220uC until further analysis. For
DNA measurements, aliquots of cell suspensions were treated with
a fluorescent DNA-binding dye (Hoechst 33258, pentahydrate-bis-
benzimide; Invitrogen). The fluorescence intensity was measured
using a SpectraMax M2 microplate reader (excitation and
emission wavelengths were set at 355 nm and 460 nm
respectively) and converted to DNA concentration by com-
parison to a standard curve for calf thymus DNA (Sigma-
Aldrich) with concentrations ranging from 0 to 40 mg/ml.
Cytochrome P450 enzyme activity (CYP1A1/2 and
CYP3A). Cytochrome P450-dependent ethoxyresorufin o-
dealkylase (EROD) or benzyloxyresorufin o-dealkylase (BROD)
activity was induced by adding 3-methylcholanthrene (3MC, Sigma-
Aldrich, 2 mM) or dexamethasone (Sigma-Aldrich, 37.5 mM),
respectively, to the hepatocyte cultures 48h prior to conducting
measurements. Cytochrome-P450 dependent EROD or BROD
detoxification activity was measured using ethoxyresorufin or
benzyloxyresorufin as substrate. The incubation mixture contained
the appropriate resorufin substrate (5 mM) and 80 mMd i c u m a r o l
diluted in EBSS (Invitrogen) [29,30,36]. Aliquots (100 mL) were
taken at 5, 15, 25, and 35 minutes after adding the resorufin
mixture, transferred to a 96-well plate and the fluorescence intensity
was measured using a SpectraMax M2 microplate reader (excitation
and emission wavelengths were set to 530 nm and 580 nm
respectively). Fluorescence intensity was converted to values of
concentration by comparison to a standard curve for resorufin
fluorescence with concentrations ranging from 0 to 1000 nM. The
rate of resorufin formation (nM/min) was calculated from the early
linear increase in the fluorescence curve, normalized to the DNA
content in hepatocytes, and defined as cytochrome P450 isoenzyme
activity. The absolute values obtained on day 12 for EROD or
BROD activity were divided by the baseline activity on day 4 to
obtain values of fold change.
Di-peptyl peptidase IV (DPP IV) immunostaining to
image bile canaliculi. Hepatocyte monolayers as well as
rLSEC-Hepatocyte and rLSEC-PEM-Hepatocyte cultures were
fixed in a 2% glutaraldehyde/PBS solution, followed by per-
meabilization for in a 0.1% Triton X-100 solution. The cultures
were incubated overnight at 4uCi na1 %B S A / P B Ss o l u t i o n .T h e
samples were incubated with a mouse monoclonal antibody to rat
DPP IV (Cell Sciences, Canton, MA) and a secondary FITC-
conjugated rabbit anti-mouse IgG antibody (Sigma-Aldrich) and
imaged using an inverted Zeiss LSM510 confocal microscope [37,38].
Statistical analysis. All data are reported as mean 6
standard deviation (S.D.). t-tests were conducted to detect
differences in the mean values between day 4 and day 12 for
each culture. p-values were adjusted for multiple hypothesis testing
using the Bonferroni correction. Statistically significant samples at
an alpha of 0.05 are denoted with an asterisk (*).
Results
rLSECs were seeded at concentrations of either 5K, 10K, 25K
or 50K above PEM-coated primary hepatocytes. In addition, the
3D Liver Cultures Maintain Hepatic Cell Phenotypes
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5 to 30. Preliminary studies indicated that using 5K and 10K
LSECs or PEMs comprised of greater than 15 layers did not
maintain or enhance hepatocellular phenotypic functions (data not
shown). Therefore, we focused our attention on 25K or 50K
rLSECs and PEMs comprised of either 5 or 15 layers. In order to
determine whether rLSECs would adhere to the underlying PEM,
they were incubated with a red-fluorescent non-toxic membrane
permeable dye prior to seeding. Images taken over a period of
twelve days demonstrated that rLSECs where only adherent when
a chitosan-HA PEM was present (Figure 1). In the absence of the
PEM (denoted as rLSEC-Hepatocyte), rLSECs were not observed
24h post-seeding. Over the culture period, rLSECS proliferated
only above the PEM-coated hepatocytes (denoted as rLSEC-PEM-
Hepatocyte), indicated by an increase in the area occupied by
these cells. These trends prevailed when the PEM was comprised
of either 5 or 15 PE layers and at an initial LSEC seeding density
of either 25K or 50K (denoted as 25K rLSEC-5L-Hepatocytes,
25K rLSEC-15L-Hepatocytes, 50K rLSEC-5L-Hepatocytes, and
50K rLSEC-15L-Hepatocytes).
In LSECs, a cell-surface marker, recently identified as Cd32b,
binds to the SE-1 antibody providing a convenient method to
validate their phenotype [25,39]. Immunostaining for the SE-1
antibody was conducted on days 4 and 12 for rLSECs cultured as
a monolayer, with hepatocytes (rLSEC-Hepatocyte) and with
PEM-coated hepatocytes (rLSEC-PEM-Hepatocyte). Four days
after the isolation of rLSECs from the liver, rLSEC monolayers
only exhibited weak fluorescence (Figure 2A) and rLSECs
cultured with hepatocytes in the absence of a PEM appeared to
have dedifferentiated (Figure 2B). However, 50K LSEC-5L-
Hepatocyte and 50K LSEC-15L-Hepatocyte cultures maintained
their phenotype, as indicated by green fluorescence (Figure 2C
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Figure 1. Merged phase-contrast (hepatocytes) and fluorescent images of red-fluorescent rLSECs. Images obtained on day 4 (A–F) and
day 12 (G–L) after isolation of hepatocytes and rLSECs. A. 25K rLSEC-Hepatocyte, B. 50K rLSEC-Hepatocyte, C. 25K rLSEC-5L-Hepatocyte, D. 50K rLSEC-
5L-Hepatocyte, E. 25K rLSEC-15L-Hepatocyte, F. 50K rLSEC-15L-Hepatocyte. Figures G–L represents the same conditions as in A–F.
Hep=Hepatocytes. Scale bar=50 microns.
doi:10.1371/journal.pone.0015456.g001
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Figure 2. SE-1 immunostaining to monitor rLSEC phenotype, images obtained on day 4 in culture. A. rLSEC monolayer, B. 50K rLSEC-
Hepatocyte, C. 50K rLSEC-5L-Hepatocyte, and D. 50K rLSEC-15L- Hepatocyte. Scale bar=50 microns.
doi:10.1371/journal.pone.0015456.g002
A B
CD
Figure 3. SE-1 immunostaining to monitor rLSEC phenotype, images obtained on day 12 in culture. A. rLSEC monolayer, B. 50K rLSEC-
Hepatocyte, C. 50K rLSEC-5L-Hepatocyte, and D. 50K rLSEC-15L- Hepatocyte. Scale bar=50 microns.
doi:10.1371/journal.pone.0015456.g003
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fluorescence. In contrast, rLSEC-PEM-Hepatocyte cultures ex-
hibited bright green fluorescence (Figure 3). These results
indicated that rLSECs maintained their phenotype in the 3D
hepatic models.
Urea and albumin production were monitored to determine
whether the presence of rLSECs would stabilize or enhance
hepatocyte function. These are two reliable markers of hepatocel-
lular performance [12,13]. Urea production monitored over a 12
day period indicated a decrease of 60%, 48% and 50% in
hepatocyte monolayers (HMs), 25K rLSEC-Hepatocyte and 50K-
rLSEC cultures respectively between day 4 and day 12
(Figure 4A) . In contrast, urea production either remained stable
or increased in the rLSEC-PEM-Hepatocyte samples. For
example, urea production increased approximately 18%, 10%
and 20% in the 25K rLSEC-5L-Hepatocytes, 50K rLSEC-5L-
Hepatocytes, and 50K rLSEC-15L-Hepatocytes, respectively.
Hepatocyte monolayers exhibited a decrease in albumin
production by approximately 65% over the 12 day observation
period (Figure 4B). 25K rLSEC-Hepatocyte samples exhibited a
decrease of approximately 16% and 50K rLSEC-Hepatocyte
cultures exhibited an increase of 28%. In contrast, all the 3D
Figure 4. Urea secretion and albumin production over a 12 day culture period. A. Urea production B. Albumin secretion. An asterisk (*)
indicates a statistically significant increase on day 12 in comparison to HMs. Hep=hepatocytes.
doi:10.1371/journal.pone.0015456.g004
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albumin production. Specifically, the fold increases were 3.4, 5.7,
3.3, and 4.5 for 25K rLSEC-5L-Hepatocytes, 25K rLSEC-15L-
Hepatocytes, 50K rLSEC-5L-Hepatocytes and 50K rLSEC-15L-
Hepatocytes samples respectively. The increase in albumin
secretion was statistically significant in each rLSEC-PEM-
Hepatocyte cultures in comparison to hepatocyte monolayers
with p-values lower than 0.05.
Cytochrome P450 enzymatic activity is another critical function
of hepatocytes. This class of enzymes mediates the metabolism of
multiple toxins, xenobiotics and pharmaceuticals [40–43]. Cyto-
chrome P4501A1/2 (CYP1A1/2) and CYP3A activities were
monitored in all cultures on days 4 and 12. Our goal was to
determine if the enzymatic kinetics increased or decreased over the
observation period, since decreasing enzymatic activity is usually
exhibited due to deteriorating phenotype. Thus, we report the
difference in CYP enzyme activity as a fold change between day 4
and day 12. CYP1A1/2 activity decreased by approximately 44%
in hepatocyte monolayers and up to 67% in rLSEC-Hepatocyte
cultures (Figure 5A). All rLSEC-PEM-Hepatocyte samples
exhibited an increased CYP1A1/2 activity, with the fold increase
ranging from 2.6 to 4.6. The greatest increase was observed in
50K rLSEC-15L-Hepatocyte samples. The increase in enzymatic
activity in each rLSEC-PEM-Hepatocyte cultures was found to be
statistically higher (p-value,0.05) in comparison to hepatocyte
monolayers. A similar trend was observed for CYP3A enzymatic
activity (Figure 5B). CYP3A enzymatic activity decreased by
approximately 27%, 87%, and 87% in hepatocyte monolayers,
Figure 5. Fold change in CYP enzyme activity over a 12 day culture period. A. CYP1A1/2 B. CYP3A. An asterisk (*) indicates a statistically
significant increase on day 12 in comparison to HMs. Hep=hepatocytes.
doi:10.1371/journal.pone.0015456.g005
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respectively. In contrast, CYP3A enzymatic activity increased in
all rLSEC-PEM-Hepatocyte samples. The increase was 3–6 fold
and was statistically significant in comparison to hepatocyte
monolayers (p-value,0.05). Once again, the greatest increase was
observed in 50K rLSEC-15L-Hepatocyte samples.
Immunostaining was conducted to determine the presence of
bile canaliculi. These are channels through which bile acids are
shuttled between the liver and intestines. Their presence indicates
the polarization of hepatocytes [44,45]. Hepatocyte monolayers
and rLSEC-Hepatocyte cultures did not exhibit these channels on
day 12 (Figure 6). In contrast, all four rLSEC-PEM-Hepatocyte
samples exhibited well-defined canaliculi.
Discussion
Due to the rapid dedifferentiation of hepatic parenchymal and
non-parenchymal cells after they are isolated from the liver, the
development of in vitro liver-like tissues has been non trivial. A liver
model that recapitulates key features of hepatic sinusoids is a
potentially powerful medium for obtaining comprehensive knowl-
edge on metabolism, detoxification and signaling pathways. A
critical component in the development of such a model is
maintaining the phenotype of hepatic cells in vitro. As a first step
towards establishing such a liver model, we have assembled 3D
hepatic architectures comprised of primary hepatocytes, rLSECs
and a polyelectrolyte-derived interface that acts as the Space of
Disse. This model mimics the stratified structure of the liver in vivo
and incorporates the two major cell types found in this organ.
Recent reports have emphasized the difficulty in maintaining
LSEC phenotype beyond a few days in monolayer or co-cultures
[24–26]. In the hepatic model reported herein, only rLSECs
cultured in an rLSEC-PEM-Hepatocyte construct exhibited
binding to the SE-1 antibody twelve days after isolation from
the liver. Both monolayers of LSECs and cultures that did not
contain a PEM exhibited a loss in phenotype after four days, a
A B C
D EF
G
Figure 6. Dipeptidyl peptidase IV (DPP IV) immunostaining for bile canaliculi obtained on day 12 in culture. A. HM, B. 25K rLSEC-
Hepatocyte, C. 50K rLSEC-Hepatocyte, D. 25K rLSEC-5L-Hepatocyte, E. 25K rLSEC-15L-Hepatocyte, F. 50K rLSEC-5L-Hepatocyte, G. 50K rLSEC-15L-
Hepatocyte. Scale bar=50 microns.
doi:10.1371/journal.pone.0015456.g006
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properties of the PEM, specifically the modulus that closely
mirrors bulk liver modulus, may have played a critical role in
rLSEC adhesion. In addition, the high degree of hydration of the
PEM may have potentially modulated inter-cellular signaling [30].
We hypothesize that cultures with lower concentrations of rLSECs
(5000 or 10,000) did not maintain hepatocellular functions due to
lower heterotypic cell-cell interactions. PEMs with greater than 15
layers also did not exhibit optimal function. One potential reason
could be that the longer deposition process as well as the higher
concentration of the polyelectrolytes could have resulted in
imparting stress to hepatocytes.
A significant finding of our study was the three-six fold increase
in albumin production in rLSEC-PEM-Hepatocyte cultures.
These trends clearly indicate that hepatocellular functions are
maintained as well, since albumin is one of the key markers of
hepatic function. In contrast, previous reports on 2D co-cultures of
rLSECs and hepatocytes, show that albumin secretion decreased
as a function of time [25]. We hypothesize that that higher
albumin secretion in our 3D models is due to significantly higher
hepatocyte-rLSEC heterotypic interaction in comparison to
conventional 2D co-cultures. These data further underscore the
need for tissue engineered liver models that recapitulate the
layered hepatic architecture found in vivo.
Optimal CYP enzymatic activity in hepatocytes is critical for the
liver to conduct detoxification of a wide range of toxins, drugs and
xenobiotics. Since LSECs are often the first cell type that comes in
contact with a drug or toxin, models that do not include these cells
will not provide relevant information required for therapeutic
strategies of the future. A recent study showed that when a
combination of alcohol and acetoaminophen was administered to
the liver, significant rLSEC death and loss of actin cytoskeletal
organization occurred [3]. A more significant outcome of this
report was that LSECs were affected a few hours prior to any
effect on hepatocytes. Thus, in vitro cultures that do not include
LSECs cannot capture the unique inter-cellular mechanisms that
govern detoxification and the subsequent effect on other liver
metabolites.
We focused our attention on two major classes of CYP enzymes,
CYP1A1/2 and CYP3A, since these enzymes typically mediate
the metabolism of polyaromatic compounds and pharmaceuticals.
Once again, the rLSEC-PEM-Hepatocyte cultures exhibited
increasing enzymatic activity over the twelve day observation
period. These trends were mirrored in the immunostaining
experiments for bile canaliculi. Multiple cytochrome P450
enzymes are often involved in the biotransformation of bile acids
[45–47]. Furthermore, bile canaliculi are the channels through
which metabolites of the detoxification processes are transported
away from the liver. Therefore, together these data suggest that
rLSEC-PEM-Hepatocyte cultures are highly suitable models to
monitor the effects of drugs and toxins on the liver.
Complications arising from drug-drug and drug-toxin interac-
tions are becoming an increasing concern for human health.
There is a need to develop liver-like tissue models that can serve as
accurate models for drug and toxicity testing. Such models cannot
rely on the use of a single hepatic cell type. Instead, the inclusion of
multiple cell types found in the liver is a pre-requisite to obtaining
a comprehensive overview on all perturbed liver functions. In the
current study, the inclusion of hepatocytes and rLSECs in a
layered 3D model resulted not only in the simultaneous
maintenance of their individual phenotype but also in increased
hepatocellular functions. The intricate inter-cellular signaling
pathways through which these cells communicate within the 3D
liver model will be the focus of future studies.
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